USD 8.9 billion
U.S. Contraceptive Market Size, Share, and Growth Analysis
U.S Contraceptive Market By Type (Drug, Devices), By Age Group (13-19 Years, 20-29 Years) - Industry Forecast 2025-2032
Report ID:
SQMIC35I2325 |
Region:
Country |
Published Date: January, 2025
Pages:
157
|Tables:
95
|Figures:
78
Format -
U.S. Contraceptive Market Insights
U.S. Contraceptive Market size was valued at USD 8.9 billion in 2023 and is poised to grow from USD 9.32 billion in 2024 to USD 13.46 billion by 2032, growing at a CAGR of 4.7% during the forecast period (2025-2032).
The US contraceptive market plays a particularly important role in the overall scheme of the healthcare system, fueled by the rising rates of the prevalence of knowledge of choice options, availability to access reproductive health and development in contraceptive solutions. The market has a central function of fulfilling the need for proper birth control, prevention of unwanted pregnancies, and helping people to make adequate decisions about their reproductive systems. Major drivers for this market growth are the increasing adoption of Long-Acting Reversible Contraceptive (LARCS) including IUDs and implants. According to the Guttmacher Institute, LARCs usage among US women aged 15–44 year also rose from 2.4% in 2002 to over 10% in recent years, suggesting that women are now more concerned with better, easier and more long-term methods.
In addition, oral contraceptives are still at the heart of the product with millions of women trusting the external aid in maintaining an adequate level of birth control. According to the CDC, 12.6% of women in the US between age 15 and 49 are on oral contraception, meaning the pill is still popular even with the many choices available. Some of the ACA policy changes and other healthcare reforms have laid important foundations through requiring insurance companies to regularly include contraception within the bearer's insurance policy without any co-payments. This has made it to be produced in larger quantities for the young women and other minimized groups.
Vigorous investment in contraceptive education and services both in the public and private domains also contributes to the increasing demand for contraceptive products.
For instance, there are federal programs such as title X that have been so helpful in offering cheap contraceptives to those of low income. In addition, the high technology like telemedicine services and contraceptive delivery applications have made it easier for people to access the contraceptives and consulting hence strengthening the market and its development.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Contraceptive Devices
Fastest Growth
Contraceptive Devices
Growth Rate
4.7% CAGR
U.S. Contraceptives Market ($ Mn)
Country Share for US (%)
To get more reports on the above market click here to Buy The Report
U.S. Contraceptive Market Segments Analysis
Global U.S. Contraceptive Market is segmented by Product, Age Group, End User and region. Based on Product, the market is segmented into Pills, Intrauterine Devices (IUD), Condoms, Vaginal Ring, Subdermal Implants, Injectable and Others. Based on Age Group, the market is segmented into 15-44 Years and Above 44 Years. Based on End User, the market is segmented into Households, Clinics and Hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Analysis by Type
Contraceptive devices, which include intrauterine devices (IUDs), implants, and condoms, dominate the U.S. market with a significant 64.76% market share. This segment is expected to grow at a robust CAGR of 4.7%. The rise in the demand for long-acting reversible contraception (LARC) methods, such as IUDs and implants, drives the growth of this segment. These devices are preferred due to their long-term effectiveness, low maintenance, and non-hormonal options. With continued innovations in product design and technological advancements, the market share of contraceptive devices is projected to increase further, making it the fastest-growing segment in the U.S. market.
Contraceptive drugs, including hormonal pills, injectables, and emergency contraception, hold a market share of 35.24% in the U.S. contraceptive market. The segment is projected to grow at a compound annual growth rate (CAGR) of 4.6%. These drugs are popular due to their convenience, wide availability, and efficacy in preventing pregnancy. Despite the dominance of contraceptive devices, the drug segment benefits from high awareness, governmental healthcare support, and the rising trend toward self-managed contraception. However, growth remains slower compared to devices due to the increasing preference for long-acting reversible contraceptives (LARCs).
Analysis by Distribution channel
The offline segment holds a dominant position in the U.S. Contraceptive Market, accounting for 85.7% of the market share. This segment primarily includes sales through physical retail stores, such as pharmacies, drugstores, and supermarkets, where consumers can purchase contraceptive products. The offline market benefits from the established consumer trust in physical locations, along with the ability to receive immediate product access. Additionally, healthcare professionals and clinics continue to recommend and distribute contraceptives, further boosting the offline segment's stronghold. This stable, well-established sales channel is expected to continue playing a significant role in the market.
The online segment is the fastest-growing channel in the U.S. Contraceptive Market, driven by increasing consumer preference for the convenience of e-commerce platforms. With a growing number of online retailers offering discreet delivery options and a wider range of products, this segment has seen a surge in demand. The online market benefits from its ability to reach a broader audience, especially younger generations who are more inclined to shop online. Additionally, the rise of telemedicine and online consultations with healthcare professionals is further fueling the online market's expansion, with a projected CAGR of 5.6%.
U.S. Contraceptives Market By Type
To get detailed analysis on other segments, Request For Free Sample Report
U.S. Contraceptive Market Regional Insights
U.S. contraceptive market is experiencing steady growth, driven by increasing awareness of reproductive health and the availability of advanced contraceptive options. Our study reveals that the market is segmented into hormonal and non-hormonal methods, with hormonal contraceptives, including oral pills, implants, and IUDs, holding the largest share. The rising preference for long-acting reversible contraceptives (LARCs) is a key trend, as they offer convenience and higher efficacy rates.
The demand for contraceptives is also influenced by government policies, healthcare accessibility, and social acceptance, with family planning services playing a crucial role in promoting contraceptive use. Additionally, the growing focus on women's health and the availability of over-the-counter options are expected to boost the market further. Major players in the U.S. contraceptive market are focusing on product innovation and strategic partnerships to address the diverse needs of consumers and expand their market presence.
U.S. Contraceptives Market By Country
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
U.S. Contraceptive Market Dynamics
U.S. Contraceptive Market Driver
Rising STI awareness drives demand for dual-protection contraceptives in the U.S. market
- The high prevalence of STIs within the U.S. is a primary driver in the contraceptive market, as it has been estimated to be over 2.4 million reported cases in 2023. With such growing concern among sexually active individuals, there is an increased demand for dual-protection methods. Public health campaigns and the 2024 STI Prevention Conference, with over 1,200 attendees and 251 poster presentations, indicate that the need for using contraceptives has increased for preventing pregnancyand STIs. Condoms have become the favorite barrier method that is fueling market growth.
Advanced IUDs, IUSs, and biodegradable implants are driving growth in the U.S. contraceptive market
- The adoption of advanced contraceptive technologies, such as intrauterine devices (IUDs) and intrauterine systems (IUSs), is driving the U.S. contraceptive market. With growing popularity among younger women, these long-acting, reversible methods offer convenience, effectiveness, and reversibility. Innovations like smaller, frameless IUDs and biodegradable implants are further fueling market growth by enhancing user compliance and convenience.
U.S. Contraceptive Market Restraint
Side effects and health risks, like depression and blood clots, hinder hormonal contraceptive adoption in the U.S. market
- Side effects and health concerns are significant barriers in the U.S. contraceptive market, with 32% of women expressing worries about side effects and 22% indifferent to pregnancy. Hormonal methods can cause side effects like weight gain, mood swings, and an increased risk of blood clots, while long-term use of Depo-Provera may reduce bone density by 20-30%.
Request Free Customization of this report to help us to meet your business objectives.
U.S. Contraceptive Market Competitive Landscape
The U.S. contraceptive market is highly competitive, with a diverse range of products and key players. The market is primarily driven by the growing awareness of reproductive health and increasing adoption of long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants. Prominent players like Bayer AG, Johnson & Johnson, and Pfizer dominate with a strong product portfolio that includes oral contraceptives, condoms, and hormonal devices. The market also sees rising competition from newer entrants offering innovative products like non-hormonal contraceptives, emergency contraceptive pills, and male contraceptives, gaining traction due to shifting consumer preferences for alternatives. Additionally, strategic collaborations and product launches, such as Bayer's IUD advancements and innovative contraceptive pills by HRA Pharma, further intensify competition. The regulatory landscape, evolving consumer demands, and ongoing investments in R&D are expected to shape the competitive dynamics, with companies focusing on accessibility, affordability, and sustainability.
Top Players in U.S. Contraceptive Market
- Pfizer Inc. (United States)
- Merck & Co., Inc. (United States)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bayer AG (Germany)
- Organon & Co. (United States)
- Agile Therapeutics, Inc. (United States)
- TherapeuticsMD, Inc. (United States)
- Mithra Pharmaceuticals (Belgium)
- Reckitt Benckiser Group plc (United Kingdom)
- Church & Dwight Co., Inc. (United States)
- The Cooper Companies, Inc. (United States)
- AbbVie Inc. (United States)
- Viatris Inc. (United States)
- Amneal Pharmaceuticals, Inc. (United States)
- Afaxys, Inc. (United States)
US Contraceptive Market Recent Developments
- In September 2024, CooperSurgical introduced a new single-hand inserter for its Paragard® Intrauterine Copper Contraceptive, which has recently received FDA approval. This innovation streamlines the insertion process, making it more accessible for both healthcare providers and patients. Paragard, a hormone-free IUD with over 30 years of clinical history, provides more than 99% efficacy for up to 10 years and offers immediate reversibility. A 2023 survey revealed that 91% of users aged 25-50 expressed satisfaction with the product. The newly available inserter features an intuitive design, enhancing convenience while maintaining the product’s reliability.
- In March 2024, Perrigo Company announced that the U.S. FDA has granted approval for Opill®, the first-ever over-the-counter (OTC) progestin-only daily oral contraceptive, suitable for all age groups. This landmark approval seeks to enhance access to contraception, addressing a crucial gap, as 45% of pregnancies in the U.S. are unintended. Backed by leading medical organizations, Opill® is recognized as a safe and effective pregnancy prevention method. The product is set to be available both online and in stores by early 2024, marking a significant advancement in women's health and empowerment.
- In October 2023, Xiromed LLC announced the U.S. launch of EnilloRing® (etonogestrel/ethinyl estradiol vaginal ring), a generic version of Nuvaring®, further expanding its women’s health portfolio. Developed and manufactured by Laboratorios Leon Pharma SAU in Spain, this product highlights Insud Pharma’s commitment to advanced technologies. EnilloRing® joins Xiromed's range of contraceptive options in the U.S., a market where Nuvaring® and its generics achieved $528 million in sales for the year ending July 2023. Xiromed is known for offering high-quality generics, including injectables and inhalation products, in the U.S. market.
U.S. Contraceptive Key Market Trends
- Rising consumer demand for safer, natural contraceptive options: A meteoric increase in research and investment in non-hormonal contraceptives was spurred by high consumer demand for alternatives to hormonal contraceptives, coupled with the increasingly alarming side effects and health risks associated with hormonal birth control. Active efforts are being made to develop and test non-hormonal methods such as copper IUDs, fertility awareness-based methods, and barrier options like condoms and diaphragms. This will have a major impact on the future growth of the non-hormonal contraceptive market, as this demand is from safer and more natural alternatives. According to the Guttmacher Institute, 30% of women are interested in non-hormonal methods due to hormonal birth control side effects and health risks, which was reported by a 2021 survey. The increasing interest in non-hormonal contraceptives reflects a growing consumer awareness of the long-term effects of hormonal methods and a larger market shift toward holistic wellness.
- Declining unintended pregnancy rates reflect growing demand for effective, accessible contraceptive solution: The decrease in unintended pregnancy rates in the U.S., from 42.1 per 1,000 women aged 15-44 in 2010 to 35.7 in 2019, highlights the growing demand for effective contraceptive solutions. This trend reflects increased public awareness, improved accessibility, and a wider range of contraceptive options, including long-acting reversible contraceptives (LARCs) and non-hormonal methods. Cultural shifts towards shared responsibility in family planning, along with strong policy advocacy for reproductive rights, have also played key roles. The continued need for innovative, safe, and accessible contraceptive methods drives ongoing research and development, ensuring that diverse consumer needs are addressed and that the positive trend in reducing unintended pregnancies is sustained.
U.S. Contraceptive Market SkyQuest Analysis
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that collects, collates, correlates, and analyzes data gathered through primary exploratory research, supported by robust secondary desk research. SkyQuest has identified the key dominating segments of the Scented candles market by offerings and applications.
According to our analysis, the U.S. contraceptive market is experiencing steady growth, driven by factors such as increased awareness, access to healthcare, and evolving consumer preferences. Our study reveals that oral contraceptive continue to dominate the market, accounting for a significant share due to their convenience and efficacy. Additionally, long-acting reversible contraceptive (LARCs) like intrauterine devices (IUDs) and implants are witnessing growing adoption as they offer extended protection and ease of use.
Innovations in contraceptive methods are also driving the market, as non-hormonal options are gaining popularity to address the increasing demand for alternative methods because of side effects. Increased funding in healthcare, pro-government policies, and the adoption of telehealth for accessing contraceptive further support the growth of the market.
However, factors such as socio-economic barriers, lack of insurance coverage, and differing state regulations could potentially hamper market expansion in some areas.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 8.9 billion |
| Market size value in 2032 | USD 13.46 billion |
| Growth Rate | 4.7% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on U.S. Contraceptive Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on U.S. Contraceptive Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the U.S. Contraceptive Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the U.S. Contraceptive Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the U.S. Contraceptive Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the U.S. Contraceptive Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
